Patents by Inventor Markus Ege

Markus Ege has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220263145
    Abstract: A lithium-ion battery and method for cycling lithium-ion batteries. The method includes providing a lithium-ion battery comprising a cathode, an anode, a separator and an electrolyte. The anode contains pre-lithiated silicon having a degree of pre-lithiation ?1 of from 5 to 50% and the anode material is only partially lithiated during full charging of the lithium-ion battery by the lithiation capacity of silicon being utilized to a degree of lithiation ?2 of from 5 to 50% by the partial lithiation of the anode material during full charging of the lithium ion battery. The total degree of lithiation ? of the silicon is from 10 to 75%, the total degree of lithiation ? is the sum of the degree of pre-lithiation ?1 and the degree of lithiation ?2, where the figures in % are based on the maximum lithiation capacity of silicon.
    Type: Application
    Filed: May 21, 2019
    Publication date: August 18, 2022
    Applicant: Wacker Chemie AG
    Inventors: Rebecca Bernhard, Markus Ege, Stefan Haufe
  • Patent number: 9950017
    Abstract: The present invention relates to a pharmaceutical composition which includes naturally occurring, non-transgenic isolated bacteria from the group of Lactococcus and Acinetobacter or fragments thereof or mixtures thereof, to such a bacterium as a medicament for the prevention and/or treatment of allergic or chronic inflammatory disorders and to a process for producing this composition.
    Type: Grant
    Filed: March 3, 2008
    Date of Patent: April 24, 2018
    Assignees: FORSCHUNGSZENTRUM BORSTEL, RUHR-UNIVERSITÄT BOCHUM
    Inventors: Albrecht Bufe, Otto Holst, Harald Renz, Erika Von Mutius, Johann Bauer, Nicole Blumer, Jennifer Debarry, Markus Ege, Susanne Friedrich, Holger Garn, Soren Gatermann, Anna Hanuszkiewicz, Holger Heine, Michael Wegmann
  • Publication number: 20080305089
    Abstract: The present invention relates to a pharmaceutical composition which includes naturally occurring, non-transgenic isolated bacteria from the group of Lactococcus and Acinetobacter or fragments thereof or mixtures thereof, to such a bacterium as a medicament for the prevention and/or treatment of allergic or chronic inflammatory disorders and to a process for producing this composition.
    Type: Application
    Filed: March 3, 2008
    Publication date: December 11, 2008
    Applicant: Protectimmun GmbH
    Inventors: Albrecht Bufe, Otto Holst, Harald Renz, Erika von Mutius, Johann Bauer, Nicole Blumer, Jennifer Debarry, Markus Ege, Susanne Friedrich, Holger Garn, Soren Gatermann, Anna Hanuszkiewicz, Holger Heine, Michael Wegmann
  • Publication number: 20080132699
    Abstract: The invention relates to a new process for the preparation of pyrazine derivatives of formula (I), which are useful as intermediates for the preparation of liquid crystalline media components or of pharmaceutically active substances.
    Type: Application
    Filed: March 31, 2005
    Publication date: June 5, 2008
    Inventors: Markus Ege, Wolfgang Jenni, Thomas Von Hirschheydt, Edgar Voss